Literature DB >> 3720755

The multifactor primary prevention trial in Göteborg, Sweden.

L Wilhelmsen, G Berglund, D Elmfeldt, G Tibblin, H Wedel, K Pennert, A Vedin, C Wilhelmsson, L Werkö.   

Abstract

The effect of a multifactorial intervention programme on coronary heart disease (CHD), stroke incidence and total mortality was determined in a random sample of men, 47-55 years old at entry. The intervention group comprised 10 004 men, and the two control groups were of similar size. The intervention consisted of antihypertensive treatment in subjects with screening blood pressure above 175 mmHg systolic or 115 mmHg diastolic, dietary advice to men with serum cholesterol levels above 260 mg per 100 ml (= 6.8 mMol l-1), advice to stop smoking to subjects who smoked more than 15 cigarettes per day. The intervention was applied for 10 years during which time CHD and stroke incidence and mortality were followed by means of special registers. Participation rate at first screening examination was 75%. The risk factor levels, i.e. blood pressure, serum cholesterol and smoking decreased markedly during 10 years in the intervention group, but also among the control groups. Total mortality, stroke and CHD incidence did not differ significantly between the intervention group and any of the two control groups. We conclude that a decrease has taken place in all three major risk factors for CHD in the general male population in Göteborg, Sweden. Strategies other than intervention on high-risk individuals must be chosen if a major impact on disease incidence is to be achieved in the general population.

Entities:  

Mesh:

Year:  1986        PMID: 3720755     DOI: 10.1093/oxfordjournals.eurheartj.a062065

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  50 in total

1.  Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.

Authors:  Sebastian Nuding; Henning Ebelt; Robert S Hoke; Annette Krummenerl; Andreas Wienke; Ursula Müller-Werdan; Karl Werdan
Journal:  Clin Res Cardiol       Date:  2011-06-03       Impact factor: 5.460

2.  Association of cigarette smoking and metabolic syndrome in a Puerto Rican adult population.

Authors:  William A Calo; Ana P Ortiz; Erick Suárez; Manuel Guzmán; Carmen M Pérez; Cynthia M Pérez
Journal:  J Immigr Minor Health       Date:  2013-08

3.  Common clinical practice versus new PRIM score in predicting coronary heart disease risk.

Authors:  Ruth Frikke-Schmidt; Anne Tybjærg-Hansen; Peter Schnohr; Gorm B Jensen; Børge G Nordestgaard
Journal:  Atherosclerosis       Date:  2010-07-27       Impact factor: 5.162

4.  When it comes to lifestyle recommendations, more is sometimes less: a meta-analysis of theoretical assumptions underlying the effectiveness of interventions promoting multiple behavior domain change.

Authors:  Kristina Wilson; Ibrahim Senay; Marta Durantini; Flor Sánchez; Michael Hennessy; Bonnie Spring; Dolores Albarracín
Journal:  Psychol Bull       Date:  2014-12-22       Impact factor: 17.737

Review 5.  Experiences from hypertension trials--effects on stroke and coronary heart disease.

Authors:  G Berglund
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 6.  Perspectives of I(f) inhibition by ivabradine in cardiology.

Authors:  Michael Böhm; Jan-Christian Reil
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study.

Authors:  A Rosengren; L Welin; A Tsipogianni; L Wilhelmsen
Journal:  BMJ       Date:  1989-11-04

8.  [Heart rate reduction as a therapeutic strategy: novel options].

Authors:  U C Hoppe
Journal:  Internist (Berl)       Date:  2006-12       Impact factor: 0.743

9.  Cancer incidence, mortality from cancer and survival in men of different occupational classes.

Authors:  Annika Rosengren; Lars Wilhelmsen
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

Review 10.  Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine.

Authors:  David Feldman; Terry S Elton; Doron M Menachemi; Randy K Wexler
Journal:  Vasc Health Risk Manag       Date:  2010-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.